Effectiveness of African Bitter Leaf (Vernonia amygdalina) on Blood Sugar Level among Diabetic Clients: A Systematic Review of Randomized Controlled Trials
Keywords:
Vernonia amygdalina; African bitter leaf; diabetes mellitus; blood glucose; randomized controlled trial; systematic review; herbal medicine..Abstract
Background: African bitter leaf (Vernonia amygdalina) is widely used in many African settings as a food vegetable and traditional remedy for diabetes. However, clinical recommendations should rely on randomized evidence in diabetic patients rather than on preclinical findings or anecdotal use.
Objective: To systematically review randomized controlled trials (RCTs) evaluating the effectiveness of African bitter leaf on blood sugar outcomes among diabetic clients.
Methods: This review was structured in line with PRISMA 2020 reporting guidance. Searches were conducted through 03 July 2026 across Google Scholar, PubMed-indexed records, PubMed Central, African Journals Online, journal websites, and supplementary web sources using combinations of “Vernonia amygdalina,” “African bitter leaf,” “bitter leaf,” “diabetes,” “diabetic,” “randomized,” “trial,” and glycaemic outcome terms. Eligible studies were RCTs enrolling participants with diabetes and reporting blood glucose outcomes after oral administration of bitter leaf preparations. Animal studies, in vitro studies, reviews, observational studies, and studies in non-diabetic volunteers were excluded.
Results: No eligible RCTs involving diabetic clients were identified. The searchable literature was dominated by animal studies, mechanistic studies, and narrative reviews. One accessible human randomized-order acute feeding study enrolled 16 normoglycaemic adults rather than diabetic patients and therefore did not meet the review question. That study reported lower postprandial glucose responses after 50 g Vernonia amygdalina compared with another indigenous vegetable comparator over 2 hours, but its findings cannot be generalized to diabetic clients. Contemporary reviews published in 2019, 2023, 2024, and 2025 consistently describe a major lack of clinical trials in diabetic patients. Because no eligible RCTs were found, risk-of-bias appraisal and meta-analysis were not undertaken.
Conclusion: There is currently no randomized clinical evidence to confirm that African bitter leaf improves blood sugar control among diabetic clients. Until well-designed human RCTs are completed, bitter leaf should not be recommended as an evidence-based glucose-lowering therapy in place of standard diabetes care....
Downloads
References
[1] World Health Organization. Diabetes. WHO Fact Sheet. Available from: https://www.who.int/news-room/fact-sheets/detail/diabetes.
[2] International Diabetes Federation. Diabetes facts & figures. Available from: https://idf.org/about-diabetes/diabetes-facts-figures/.
[3] International Diabetes Federation. IDF Diabetes Atlas: Africa region. Available from: https://diabetesatlas.org/data-by-location/region/africa/.
[4] Amaeze OU, et al. Herbal medicine use among Type 2 diabetes mellitus patients in Nigeria: understanding the magnitude and predictors of use. Int J Clin Pharm. 2018;40(3):580-588. doi:10.1007/s11096-018-0648-2.
[5] Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi:10.1136/bmj.n71.
[6] Okolie UV, Okeke CE, Oli JM, Ehiemere IO. Hypoglycemic indices of Vernonia amygdalina on postprandial blood glucose concentration of healthy humans. Afr J Biotechnol. 2008;7(24):4581-4585. doi:10.5897/AJB08.903.
[7] Asante DB, Wiafe GA. Therapeutic Benefit of Vernonia amygdalina in the Treatment of Diabetes and Its Associated Complications in Preclinical Studies. J Diabetes Res. 2023;2023:3159352. doi:10.1155/2023/3159352.
[8] Adinortey MB, Agbeko R, Boison D, Ekloh W, Kuatsienu LE, Biney EE, et al. Phytomedicines Used for Diabetes Mellitus in Ghana: A Systematic Search and Review of Preclinical and Clinical Evidence. Evid Based Complement Alternat Med. 2019;2019:6021209. doi:10.1155/2019/6021209.
[9] Amaeze O, et al. Cytochrome P450 Enzyme Inhibition and Herb-Drug Interaction Potential of Medicinal Plant Extracts Used for Management of Diabetes in Nigeria. Eur J Drug Metab Pharmacokinet. 2021;46(3):437-450. doi:10.1007/s13318-021-00685-1.
[10] Egbune E, Eraga LI, Ezedom T, Avwioroko OJ, Asagba SO, Tonukari NJ. Medicinal and therapeutic properties of bitter leaf (Vernonia amygdalina): A review. African Research Reports. 2025;1(7):574-585. doi:10.65221/0105.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
